Immunomodulation of the Human Prion Peptide 106–126 Aggregation

This publication has 32 references indexed in Scilit:

• Antibody binding defines a structure for an epitope that participates in the PrP C → PrP Sc conformational change 1 1Edited by I. A. Wilson
  Journal of Molecular Biology, 1999
• Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state
  The EMBO Journal, 1999
• N-terminal EFRH sequence of Alzheimer's β-amyloid peptide represents the epitope of its anti-aggregating antibodies
  Journal of Neuroimmunology, 1998
• Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins.
  Proceedings of the National Academy of Sciences, 1993
• Synthetic peptides homologous to prion protein residues 106-147 form amyloid-like fibrils in vitro.
  Proceedings of the National Academy of Sciences, 1993
• Molecular Characteristics of a Protease-Resistant, Amyloidogenic and Neurotoxic Peptide Homologous to Residues 106-126 of the Prion Protein
  Biochemical and Biophysical Research Communications, 1993
• Neurotoxicity of a prion protein fragment
  Nature, 1993
• Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy
  Biochemistry, 1991
• The αlytic protease pro-region does not require a physical linkage to activate the protease domain in vivo
  Nature, 1989
• Separation and properties of cellular and scrapie prion proteins.
  Proceedings of the National Academy of Sciences, 1986